| Elizabeth Chandler Hughes, MD | |
|
626 120th Ave Ne, Ste B104, Bellevue, WA 98005-3077 | |
| (206) 505-1000 | |
| Not Available |
| Full Name | Elizabeth Chandler Hughes |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Location | 626 120th Ave Ne, Bellevue, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952365140 | NPI | - | NPPES |
| 8471831 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD00044346 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Chandler Hughes, MD 626 120th Ave Ne, Ste B104, Bellevue, WA 98005-3077 Ph: (206) 505-1000 | Elizabeth Chandler Hughes, MD 626 120th Ave Ne, Ste B104, Bellevue, WA 98005-3077 Ph: (206) 505-1000 |
News Archive
A first-of-its-kind study published in the February issue of the Journal of Neurosurgery: Pediatrics suggests endoscopic brain surgery, pioneered by surgeons at the University of Pittsburgh Medical Center, has the potential to be safer and often more effective than conventional surgery in children with life-threatening conditions.
UC San Francisco researchers have used brain scans to predict how young children learn to read, giving clinicians a possible tool to spot children with dyslexia and other reading difficulties before they experience reading challenges.
A new drug, based on a natural extract from sea sponge, may help to extend the lives of women with advanced breast cancer, UK scientists have found. A research team at the University of Leeds and St James's Institute of Oncology led an international trial of the new chemotherapy drug, eribulin mesylate.
A new study published by the team of Naguib Mechawar, Ph.D., a researcher with the McGill Group for Suicide Studies of the Douglas Institute (CIUSSS de l'Ouest-de-l'Ile de Montreal) and associate professor in the Department of Psychiatry at McGill University, sheds new light on the disruption of astrocytes in depression.
Ascension Orthopedics, Inc., a market leader in PyroCarbon orthopedic implants, announces the first implantation of the PyroTITAN™ Humeral Resurfacing Arthroplasty outside the United States. The PyroTITAN was implanted last month in Brisbane, Australia in a 46-year-old patient who reported "immediate pain relief" within 24 hours of surgery. The PyroTITAN Humeral Resurfacing implant is the first commercially-available shoulder arthroplasty prosthesis made of PyroCarbon in the world.
› Verified 5 days ago
Julie S Francis, MD Dermatology Medicare: Medicare Enrolled Practice Location: 14030 Ne 24th St, Suite 202, Bellevue, WA 98007 Phone: 425-454-1104 Fax: 425-454-1290 | |
Samir P. Master, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1414 116th Ave Ne Ste E, Bellevue, WA 98004 Phone: 425-753-2918 | |
Keith Cameron Carlson, MD Dermatology Medicare: Medicare Enrolled Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 | |
Andy J Chien, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 Fax: 425-502-3589 | |
Dr. John P. Hackett, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1605 116th Ave Ne, Ste 102, Bellevue, WA 98004 Phone: 425-456-0709 Fax: 425-456-0358 | |
Dr. James Philip Harnisch, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1600 116th Ave Ne, #306, Bellevue, WA 98004 Phone: 425-455-5111 Fax: 425-455-5113 | |
Dr. Anjeli Krishnan Isaac, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 |